Merck (MRK) Leases (2019 - 2025)

Merck (MRK) has 7 years of Leases data on file, last reported at $1.5 billion in Q4 2025.

• Leases for Q4 2025 came in at $1.5 billion, up 10.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.5 billion (up 10.0% YoY), and the FY2025 annual result was $1.5 billion, up 10.0% from the prior year.
• Leases improved to $1.5 billion in Q4 2025 per MRK's latest filing, from $1.4 billion in the prior quarter.
• Over five years, Leases peaked at $1.6 billion in Q4 2021 and troughed at $1.3 billion in Q4 2022.
• A 5-year average of $1.4 billion and a median of $1.4 billion in 2023 frame the typical range for Leases.
• The sharpest annual moves came in 2022 and 2025: Leases dropped 15.13% in 2022, then increased 10.0% in 2025.
• A 5-year view of Leases shows it stood at $1.6 billion in 2021, then retreated by 15.13% to $1.3 billion in 2022, then rose by 6.76% to $1.4 billion in 2023, then decreased by 4.66% to $1.4 billion in 2024, then advanced by 10.0% to $1.5 billion in 2025.
• Business Quant data shows MRK's Leases at $1.5 billion in Q4 2025, $1.4 billion in Q4 2024, and $1.4 billion in Q4 2023.